Feedback Form

     (change)

Western blot - Insulin degrading enzyme / IDE antibody - Inactive domain (ab28561)
Western blot - Insulin degrading enzyme / IDE antibody - Inactive domain (ab28561)
(enlarge)


Product Name 

Insulin degrading enzyme / IDE antibody - Inactive domain

 

See all Insulin degrading enzyme / IDE antibodies (10)...

Product type 

Primary antibodies

Description 

Rabbit polyclonal to Insulin degrading enzyme / IDE - Inactive domain

Immunogen 

Synthetic peptide based on the inactive metalloproteinase domain of human Insulin degrading enzyme / IDE.(Peptide available as ab41259.)

Reacts with 

Hu

Predicted to react 
(species key)

Ms, Rat
(Due to sequence homology)

Specificity 

ab28561 recognises the inactive metalloproteinase domain of IDE.

We have a range of domain specific antibodies for this target. For a full list please see all Insulin degrading enzyme / IDE antibodies

Tested applications 
(see key)

WB


Abreviews 

Customer reviews
(see key)


Read about Abreviews

Submit an Abreview

Be the first to review this antibody and earn 220 Abpoints.


Application notes 
(see key)

Recommended dilutions
WB: 1/1000 (as a starting dilution when using colorimetric substrates such as BCIP/NBT) and 1/5000 (as a starting dilution for chemiluminescent substrates). Higher concentrations of antibody may be needed for samples from more distantly related species. Predicted molecular weight: 118 kDa. Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.



Specific protocols
Recommended WB protocol

Cellular localization 

Cytoplasmic

Research areas 

Cell Biology >> Proteolysis / Ubiquitin >> Proteolytic enzymes >> Metalloprotease >> Insulysin
Neuroscience >> Neuroendocrinology >> Obesity & Metabolism
Signal Transduction >> Growth Factors/Hormones >> Insulin / Insulin-like
Neuroscience >> Neurodegeneration >> Alzheimer's >> Other

Relevance 

Insulysin was identified nearly a century ago as an enzyme responsible for the degradation of insulin in cells, although the precise interactions between insulin and insulysin remain elusive. Human insulysin was cloned in 1988, and shown to be a 118 kDa protein that exists primarily as a homodimer, and perhaps also complexed with other molecules. The sequence is well conserved between humans, rats and mice, and the antibody recognizes these species. Insulysin is a metalloproteinase of the clan ME, family M16, which contains an active site HxxEH, a reversal of the canonical HExxH zinc binding motif. Considered a zinc metalloproteinase, the activity of insulysin can be blocked with EDTA or 1-10 phenanthroline. In addition to the active metalloproteinase domain, insulysin contains a second metalloproteinase site which is considered catalytically inactive, and is thought to assist in substrate binding. Insulysin is most closely related to the bacterial proteinase pitrilysin, (the human orthologue of which appears to be MPRP1) and the mammalian proteinsae nardilysin. Generally thought to be a cytoplasmic protein, insulysin has been isolated from many different tissues and cell lines, and can degrade intact insulin, insulin B chain, glucagon, denatured hemoglobin, alpha amyloid protein, TGF alpha and amylin. Recent work implicates insulysin in clearing beta amyloid plaques from the brain, and has generated much interest in Alzheimer’s disease research. The pH optimum for insulysin is basic, pH 8.5, which also distinguishes it from other metalloproteinases.

Insulin degrading enzyme (IDE) has a preferential affinity for insulin such that the presence of insulin will inhibit IDE mediated degradation of other substrates. IDE degrades a variety of other peptides including atrial natriuretic peptide and amylin. IDE catabolizes A beta and has been implicated as a candidate enzyme responsible for the degradation and clearance of A beta in the brain. IDE has also been shown to degrade the APP intracellular domain (AICD), a product of gamma secretase cleaved APP that may function in nuclear signaling.

 

Alternative names for Insulin degrading enzyme / IDE antibody - Inactive domain (ab28561)

Database links 

The links below go to external sites and will open in a new browser window

Entrez Gene

    

3416    (Human)
15925    (Mouse)
25700    (Rat)

GeneCard

    

GC10M094201    (Human)

Omim

    

146680    (Human)

SwissProt

    

P14735    (Human)
Q5T5N2    (Human)
Q8CGB9    (Mouse)
Q9JHR7    (Mouse)
P35559    (Rat)

Unigene

    

500546    (Human)
45029    (Rat)

Raised in 

Rabbit

Clonality 

Polyclonal

Isotype 

IgG

Purity 

Immunogen affinity purified

Storage buffer 

Preservative: 0.05% Sodium Azide
Constituents: 50% Glycerol

Material safety datasheets (MSDS) for this product:
Glycerol MSDS
Sodium Azide MSDS

Form 

Liquid

Concentration 

1.000 mg/ml

Storage instructions 

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze / thaw cycles.

 

At Abcam, we have one centralized database to hold all of our product information, so that everything we know about this Insulin degrading enzyme / IDE antibody - Inactive domain is on this datasheet. But please do contact us if you would like any reassurance!


See below for Insulin degrading enzyme / IDE antibody - Inactive domain images, references, products related to ab28561 and other tools.

 

Insulin degrading enzyme / IDE antibody - Inactive domain images:

Product image  Western blot - Insulin degrading enzyme / IDE antibody - Inactive domain (ab28561)

Western blot - Insulin degrading enzyme / IDE antibody - Inactive domain (ab28561)

All lanes : Insulin degrading enzyme / IDE antibody - Inactive domain (ab28561) at 1/1000 dilution

Lane 1 : Insulysin at 0.05 µg
Lane 2 : Insulysin at 0.01 µg
Lane 3 : Insulysin at 0.001 µg


Predicted band size : 118 kDa
Observed band size : 110 kDa (why is the actual band size different from the predicted?)

 
 

Search PubMed (MEDLINE) for references to Insulin degrading enzyme / IDE

 

Insulin degrading enzyme / IDE antibody - Inactive domain - more information

Customer reviews (feedback) regarding Insulin degrading enzyme / IDE antibody - Inactive domain

Customer FAQs regarding Insulin degrading enzyme / IDE antibody - Inactive domain

Protocols for Insulin degrading enzyme / IDE antibody - Inactive domain

Price and availability of products related to Insulin degrading enzyme / IDE antibody - Inactive domain

 

Insulin degrading enzyme / IDE antibody - Inactive domain - related products:

Products for Western blot

Loading controls

Lysates

 

Immunizing Peptide for Insulin degrading enzyme / IDE antibody - Inactive domain

ab41259

  

Insulin degrading enzyme / IDE peptide (Inactive domain)

 

Compatible Secondaries for Insulin degrading enzyme / IDE antibody - Inactive domain

ab6564

  

Cy5 ® antibody

ab6717

  

FITC antibody

ab6720

  

Biotin antibody

ab6721

  

HRP antibody

ab6722

  

Alkaline Phosphatase antibody

ab6793

  

Texas Red ® antibody

ab7007

  

Phycoerythrin antibody

ab7019

  

Agarose antibody

ab27234

  

10nm Gold antibody

ab27235

  

5nm Gold antibody

ab27236

  

15nm Gold antibody

ab27237

  

20nm Gold antibody

ab27238

  

30nm Gold antibody

ab27239

  

10nm Gold antibody

ab27240

  

5nm Gold antibody

ab31193

  

Duck polyclonal to Rabbit IgG

ab60314

  

Chromeo™ 488 antibody

ab60315

  

Chromeo™ 494 antibody

ab60317

  

Chromeo™ 546 antibody

ab60319

  

Chromeo™ 642 antibody

 

Other Insulin degrading enzyme / IDE Antibodies

See all Insulin degrading enzyme / IDE antibodies (10)...

 

Insulin degrading enzyme / IDE antibody - Inactive domain - other tools:

Contact Abcam with a Technical Enquiry about Insulin degrading enzyme / IDE antibody - Inactive domain

 

All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

©1998-2009 Abcam plc. All rights reserved. Terms and conditions · Legal · Privacy policy · Investor relations · Contact us · Blog